Cellebrite DI Ltd.
CLBT
$17.09
$0.482.89%
NASDAQ
06/30/2024 | 06/30/2024 | 03/31/2024 | |||
---|---|---|---|---|---|
Net Income | 66.64% | 66.64% | -387.28% | ||
Total Depreciation and Amortization | -3.88% | -3.88% | 2.49% | ||
Total Amortization of Deferred Charges | -- | -- | -- | ||
Total Other Non-Cash Items | -51.16% | -51.16% | 142.39% | ||
Change in Net Operating Assets | -5.14% | -5.14% | -122.44% | ||
Cash from Operations | 44.54% | 44.54% | -77.09% | ||
Capital Expenditure | -38.66% | -38.66% | 33.85% | ||
Sale of Property, Plant, and Equipment | -- | -- | -- | ||
Cash Acquisitions | -- | -- | -- | ||
Divestitures | -- | -- | -- | ||
Other Investing Activities | 61.06% | 61.06% | -1,577.59% | ||
Cash from Investing | 59.23% | 59.23% | -2,681.30% | ||
Total Debt Issued | -- | -- | -- | ||
Total Debt Repaid | -- | -- | -- | ||
Issuance of Common Stock | -34.42% | -34.42% | 11.90% | ||
Repurchase of Common Stock | -- | -- | -- | ||
Issuance of Preferred Stock | -- | -- | -- | ||
Repurchase of Preferred Stock | -- | -- | -- | ||
Total Dividends Paid | -- | -- | -- | ||
Other Financing Activities | -- | -- | -- | ||
Cash from Financing | -34.42% | -34.42% | 11.90% | ||
Foreign Exchange rate Adjustments | 91.83% | 91.83% | -164.38% | ||
Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
Net Change in Cash | 76.93% | 76.93% | -227.90% | ||